Replies to post #705913 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I referred to Outlook because they received UK and EMA approval and the stock price did not move that much.
For the market, it is important that a nonrevenue biotech clearly indicates that it will, within a reasonable timeframe, start earning positive cash flow.
This could be achieved by selling its just-approved medication or by a upfront license deal.

Unfortunately at the last ASM Powers stated that there is no license deal in sight and she said that they still need to hire consultants for negotiations with NICE.
It would have been better if Powers had not shared this information. Now the market may respond less enthusiastically to the UK approval news.
NWBO management does tend to kick all speculative elements from the stock price.

[theorysuit]

I am guessing he has signed NDA. You know he is a big big investor. Guessing End story not too far.

Pleas enough of this quiet period/nda nonsense. Big investors in NWBO? I don't see any big 13 filings anywhere. Haven't you learned this by now. They need to execute but are prioritizing building up LPs CDMOs. I wonder why someone would ask for a commercialization plan? Probably because they look like they need one....